Collplant Biotechnologies Ltd (CLGN) — Cash Flow Reinvestment Rate

Latest as of September 2023: 0.07x

Collplant Biotechnologies Ltd (CLGN) has a Cash Flow Reinvestment Rate of 0.07x as of September 2023, reinvesting $486.00K (capex $243.00K plus investments $-243.00K) from operating cash flow of $6.78 Million. Explore capital reinvestment ratio of Collplant Biotechnologies Ltd to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.07x
(Capex + Investments) / Operating CF

Total Reinvested

$486.00K
Capex + Investments

Operating Cash Flow

$6.78 Million
USD

Capital Expenditures

$243.00K
USD

Collplant Biotechnologies Ltd Cash Flow Reinvestment Rate (2021–2021)

Historical reinvestment intensity for Collplant Biotechnologies Ltd across 1 annual periods. Also explore Collplant Biotechnologies Ltd asset portfolio for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Collplant Biotechnologies Ltd (2021–2021)

Year-by-year capital reinvestment analysis for Collplant Biotechnologies Ltd. For live market cap and broader valuation context, see CLGN stock market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2021 12.57x $31.43 Million $2.50 Million $1.43 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow